SF2/ASF inhibitors belong to a distinct and significant class of chemical compounds that are recognized for their pivotal role in modulating alternative splicing processes within eukaryotic cells. Alternative splicing is a fundamental post-transcriptional mechanism through which a single pre-mRNA molecule can generate multiple mRNA isoforms, consequently diversifying the protein repertoire encoded by a single gene. SF2/ASF (Serine- and Arginine-Rich Splicing Factor 2/Alternative Splicing Factor) is a key protein that actively participates in this intricate splicing machinery. The SF2/ASF inhibitors specifically target the activity of this splicing factor, exerting their influence on the intricate splicing process. Chemically, these inhibitors typically interfere with the functional domains of SF2/ASF, particularly the regions responsible for RNA recognition and binding. This disruption leads to altered interactions between SF2/ASF and pre-mRNA molecules, consequently affecting the selection of splice sites during splicing events. The inhibitors may act by directly binding to SF2/ASF and impeding its interaction with RNA molecules, thereby influencing the specificity and efficiency of splice site selection. Alternatively, they might modulate the conformation and stability of SF2/ASF, affecting its ability to interact with other splicing components. By effectively controlling the activity of SF2/ASF, these inhibitors play a critical role in governing the balance between different splicing isoforms, ultimately contributing to the cellular proteome's diversity.
In conclusion, SF2/ASF inhibitors represent a distinctive class of chemical compounds that function as intricate regulators of alternative splicing. Through their targeted modulation of SF2/ASF, these inhibitors intricately impact the splicing process, influencing the selection of splice sites and consequently shaping the cellular protein landscape. Their specific mechanisms of action involve disrupting SF2/ASF's interactions with RNA molecules or altering its conformation, ultimately highlighting their significance in the broader context of post-transcriptional gene regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
A natural compound from Streptomyces platensis that interferes with the interaction between SF2/ASF and its target RNA sequences, leading to changes in splicing patterns. | ||||||
Herboxidiene | 142861-00-5 | sc-506378 | 1 mg | $1009.00 | ||
Another natural compound that targets the ATPase activity of SF2/ASF, disrupting its splicing function. | ||||||
FR901464 | 146478-72-0 | sc-507352 | 5 mg | $1800.00 | ||
A compound Found in microbes that affects the phosphorylation status of SF2/ASF, leading to altered splicing events. | ||||||
Platensimycin | 835876-32-9 | sc-202292 | 250 µg | $462.00 | 1 | |
An antibiotic that impacts bacterial fatty acid synthesis and also affects alternative splicing in mammalian cells through SF2/ASF. | ||||||
Isoginkgetin | 548-19-6 | sc-507430 | 5 mg | $225.00 | ||
Found in Ginkgo biloba, this compound interferes with SF2/ASF's ability to bind to RNA sequences, resulting in altered splicing. | ||||||